Search Results - "Zhilyaeva, T. V."

Homocysteine in Schizophrenia: Independent Pathogenetic Factor with Prooxidant Activity or Integral Marker of Other Biochemical Disturbances? by Zhilyaeva, T. V., Piatoikina, A. S., Bavrina, A. P., Kostina, O. V., Zhukova, E. S., Shcherbatyuk, T. G., Blagonravova, A. S., Dubinina, E. E., Mazo, G. E.

“…A wide range of studies have demonstrated that hyperhomocysteinemia is associated with the risk of schizophrenia, but currently available assumptions about the…”
Get full text

Pterin metabolism, inflammation and oxidative stress biochemical markers in schizophrenia: Factor analysis and assessment of clinical symptoms associations by Zhilyaeva, T.V., Kasyanov, E.D., Rukavishnikov, G.V., Piatoikina, A.S., Bavrina, A.P., Kostina, O.V., Zhukova, E.S., Shcherbatyuk, T.G., Mazo, G.E.

“…Various aspects of folate and tetrahydrobiopterin (BH4) metabolism disturbances have been detected in patients with schizophrenia.Data were obtained that…”
Get full text

Tetrahydrobiopterin deficiency in schizophrenia: Biochemical and clinical aspects by Zhilyaeva, T.V., Kasyanov, E.D., Semennov, I.V., Rukavishnikov, G.V., Piatoikina, A.S., Kostina, O.V., Verbitskaya, E.V., Mazo, G.E.

“…It was reported that the levels of tetrahydrobiopterin (BH4) are reduced in schizophrenia. However, mechanisms of BH4 deficiency in schizophrenia had not been…”
Get full text

Cognitive impairments in schizophrenia and their impact on oxidative stress by Piatoikina, A. S., Zhilyaeva, T. V., Mazo, G. E.

“…The article is devoted to modern concepts of cognitive disorders in schizophrenia. Neurocognitive deficits can be expressed in impaired attention, auditory…”
Get full text

Association of affective disorders and MTHFR, MTR, and MTRR gene polymorphisms: preliminary results of a family study by Kasyanov, E. D., Zhilyaeva, T. V., Maso, G. E.

“…Genetic polymorphisms associated with impaired one-carbon metabolism (1-CM) can be a risk factor not only for somatic and neurological diseases, but also for…”
Get full text

Dysbiosis of intestinal microbiota in autism spectrum disorders: new horizons in search for pathogenetic approaches to therapy. Part 1. Features of intestinal microbiota in autism spectrum disorders by Blagonravova, A. S., Zhilyaeva, T. V., Kvashnina, D. V.

“…The first part of the literature review on the role of intestinal microbiota dysbiosis in the pathogenesis of autism spectrum disorders (ASD) includes recent…”
Get full text

Disturbances of intestinal microbiota in autism spectrum disorders: new horizons in search for pathogenetic approaches to therapy. Рart 3. Рotential strategies of influence on gut-brain axis for correction of symptoms of autism spectrum disorders by Blagonravova, A. S., Zhilyaeva, T. V., Kvashnina, D. V.

“…The third part of the literature review on the role of intestinal microbiota disturbances in the pathogenesis of autism spectrum disorders (ASD) is devoted to…”
Get full text

Dysbiosis of intestinal microbiota in autism spectrum disorders: new horizons in search for pathogenetic approaches to therapy. Part 2. Gut–brain axis in pathogenesis of autism spectrum disorders by Blagonravova, A. S., Zhilyaeva, T. V., Kvashnina, D. V.

“…The second part of the literature review on the role of intestinal microbiota disturbances in the pathogenesis of autism spectrum disorders (ASD) is devoted to…”
Get full text

Interleukin-6 in schizophrenia is associated with negative symptoms, side effects of therapy and smoking: results of a pilot study by Zhilyaeva, T. V., Piatoikina, A. S., Rukavishnikov, G. V., Mazo, G. E.

“…Interleukin-6 (IL-6) is one of the most important pro-inflammatory markers with immunomodulatory activity associated with schizophrenia. The possible…”
Get full text

The interaction of folate cycle enzyme genes and the risk of extrapyramidal side effects of antipsychotics by Zhilyaeva, T. V., Akimova, E. V., Blagonravova, A. S., Mazo, G. E.

“…Personalized medicine means the selection of therapy for patients, taking into account the assessment of genetic risk factors for side effects. A number of…”
Get full text

Biochemical disturbances in schizophrenia — a «window of opportunity by Zhilyaeva, T. V., Piatoikina, A. S., Kasyanov, E. D., Rukavishnikov, G. V., Semennov, I. V., Kostina, O. V., Blagonravova, A. S., Mazo, G. E.

“…   Introduction:  Currently, there is a large amount of data that inflammatory and oxidative stress biomarkers, pterin metabolism disturbances and other…”
Get full text

Association between redox imbalance, pterin metabolism markers, and early extrapyramidal side effects of antipsychotics in schizophrenia: pilot study by Zhilyaeva, T. V., Shvachkina, D. S., Piatoikina, A. S., Zhukova, E. S., Kostina, O. V., Shcherbatyuk, T. G., Mazo, G. E.

“…Antipsychotics (AP) administration in schizophrenia patients is associated with several side effects (SE), in particular, with extrapyramidal (EP). Data…”
Get full text

The double-blind randomized placebo-controlled trial of N-acetylcysteine use in schizophrenia: preliminary results by Pyatoykina, A S, Zhilyaeva, T V, Semennov, I V, Mishanov, G A, Blagonravova, A S, Mazo, G E

“…Currently, oxidative stress as part of the pathogenesis of schizophrenia attracts much attention. In this regard, it becomes relevant to assess the level of…”
Get more information

Genetic markers of One-Carbon Metabolism Disorders in Schizophrenial by Zhilyaeva, T. V., Piatoikina, A. S., Blagonravova, A. S., Mazo, G. E.

“…The paper presents the results of the literature review and the authors’ own studies of the association of several several single-nucleotide genetic…”
Get full text

The role of nutrients and probiotics in treatment of depression by Neznanov, N. G., Rukavishnikov, G. V., Kasyanov, E. D., Ganzenko, M. A., Leonova, L. V., Zhilyaeva, T. V., Mazo, G. E.

“…Currently, a growing amount of data is emerging on the role of various environmental factors (nutrients, gut microbiota, etc.) on formation of depression. The…”
Get full text

New approach to mental disorders systematics: starting point or point of view? by Neznanov, N. G., Rukavishnikov, G. V., Kaysanov, E. D., Zhilyaeva, T. V., Mazo, G. E.

“…The search for new approaches to the mental disordersclassification is one of the priority tasks in modern psychiatry. Current approaches evaluate mental…”
Get full text

Tetrahydrobiopterin deficiency in schizophrenia as a new target for personalized medicine by Semennov, I. V., Zagryazhskaya, Y. S., Piatoikina, A. S., Zhilyaeva, T. V., Manakova A., E. A., Blagonravova, A. S., Verbitskaya, E. V., Mazo, G. E.

“…Tetrahydrobiopterin (BH4) is an important cofactor, that involved in the synthesis of dopamine, norepinephrine, and serotonin, as well as affecting the…”
Get full text

Association study of methylenetetrahydrofolate reductase genetic polymorphism 677C>T with schizophrenia in hospitalized patients in population of European Russia by Zhilyaeva, T.V., Sergeeva, A.V., Blagonravova, A.S., Kasimova, L.N., Kuznetsov, K.V., Golovanova, V.I., Shebolkova, T.B., Korshunova, E.A.

“…•Genetic polymorphism MTHFR677C>T among representatives of Russian population is a possible risk factor for schizophrenia.•This genetic factor associated with…”
Get full text

Single nucleotide polymorphism MTHFR677C>T and the severity of metabolic side effects of antipsychotics in patients with schizophrenia: the results of a pilot study by Kosataya, M. A., Marina, A. V., Sergeeva, A. V., Zhilyaeva, T. V., Blagonravova, A. S., Mazo, G. E.

“…To predict the development of side effects and personalized selection of drug therapy, it seems relevant to study the association of individual genetic risk…”
Get full text

Psychopathological characteristics and social functioning of the schizophrenic patients with the T allele of the MTHFR677C>T polymorphism by Zhilyaeva, T V, Sergeeva, A V, Blagonravova, A S, Kasimova, L N

“…To compare the severity of psychopathological symptoms and characteristics of personal and social functioning in patients with schizophrenia, carriers of…”
Get more information